SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-10-039993
Filing Date
2010-04-29
Accepted
2010-04-29 06:23:05
Documents
5
Effectiveness Date
2010-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A c99085defa14a.htm DEFA14A 37095
2 GRAPHIC c99085c9908501.gif GRAPHIC 18974
3 GRAPHIC c99085c9908502.gif GRAPHIC 3572
4 GRAPHIC c99085c9908503.gif GRAPHIC 1859
5 GRAPHIC c99085c9908504.gif GRAPHIC 3358
  Complete submission text file 0000950123-10-039993.txt   77482
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 10778744
SIC: 2836 Biological Products, (No Diagnostic Substances)